These are generally milder than the nausea, vomiting, and digestive issues commonly associated with pharmaceutical GLP-1 medications
Potential long-term outcomes: chronic gastroparesis intestinal dysmotility persistent nausea and vomiting lifelong dietary dependence gastric emptying permanently slowed Some patients report non-reversible gastroparesis even after stopping the drug
Warning: If you are pregnant, nursing, have any health condition or taking any medication, consult your health professional before using this product
Nesse estudo, a perda de peso chegou a 22,6% at 25,3 kg em 80 semanas
If you want a broader overview of how GLP-1 support fits into a treatment plan, our article on GLP-1 support and weight loss is a useful companion read